As shown in Table 3, multiple logistic regression analysis adjusted by sex and BRAF mutation showed that A variant carriers had a 3 times greater risk of early onset of cancer under the homozygote comparison model (A/A vs. T/T: OR = 3.13, 95%CI = 1.28–7.69, p = 0.034). This evidence concerns the gene BRAF and cancer.